Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.
about
Vaccines: from empirical development to rational designTranscutaneous immunization system using a hydrotropic formulation induces a potent antigen-specific antibody response.Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo.Sequential release of salidroside and paeonol from a nanosphere-hydrogel system inhibits ultraviolet B-induced melanogenesis in guinea pig skin.Adjuvants for human vaccines.Transdermal immunization: biological framework and translational perspectives.Transcutaneous antigen delivery system.Functional nanomaterials can optimize the efficacy of vaccines.Microneedles for drug delivery: trends and progress.Solid-in-oil nanodispersions for transdermal drug delivery systems.Intradermal application of vitamin D3 increases migration of CD14+ dermal dendritic cells and promotes the development of Foxp3+ regulatory T cells.Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN.Breaking the Barrier - Potent Anti-Inflammatory Activity following Efficient Topical Delivery of Etanercept using Thermoresponsive Nanogels.The Effects of Physicochemical Properties of Nanomaterials on Their Cellular Uptake In Vitro and In Vivo.Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.Transdermal immunization using solid-in-oil nanodispersion with CpG oligodeoxynucleotide adjuvants.Intradermal delivery of a fractional dose of influenza H7N9 split vaccine elicits protective immunity in mice and rats.Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles
P2860
Q21089599-FAC66661-180E-40B0-8F53-E196A9D881E1Q34460808-F2E9C77A-3D5C-40C3-AE37-330CBA26B7B6Q35656890-33DFA26A-819A-4444-83D5-D238B87B5CF1Q37721834-C07A53E7-D995-4410-A683-BA890440DC3FQ38004229-30F9E220-405C-47A7-AD85-C28A1B182F66Q38068975-109B65D2-513B-45A1-BAB2-C7E9FDAB13E9Q38076804-096914E8-1C7C-4851-9DDE-A7941AAC09A9Q38252639-C32D705C-94A6-4545-9244-64CD6CACDB42Q38297827-B6CCFEEC-05C2-4D8C-B0A8-2A030037FC92Q38830870-22FADBC1-3907-42FD-BE53-9EFBDEDDD8AAQ41865349-86D51D4B-2F5A-408C-A4EA-C6F2ABB9F28CQ42236065-20BB99F4-CBEB-4FA2-A538-A8EEDB32A900Q47098090-02476A24-8DED-4F2D-867D-9D009E022F0FQ47642966-391114FE-702A-437D-A9C9-F03B7541ACCDQ53054958-68B2792A-981C-4695-8C0A-ABB6A3F6A688Q53399813-D66CBEE4-27CB-4B9A-B3D3-43CEAC486FABQ54277728-155C39C9-571A-4691-A0B0-DC3CA4001028Q58785973-51FF95F1-F171-4965-AE9B-79322EC60E36
P2860
Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transcutaneous vaccines: novel ...... y for overcoming the barriers.
@en
Transcutaneous vaccines: novel ...... y for overcoming the barriers.
@nl
type
label
Transcutaneous vaccines: novel ...... y for overcoming the barriers.
@en
Transcutaneous vaccines: novel ...... y for overcoming the barriers.
@nl
prefLabel
Transcutaneous vaccines: novel ...... y for overcoming the barriers.
@en
Transcutaneous vaccines: novel ...... y for overcoming the barriers.
@nl
P2093
P1433
P1476
Transcutaneous vaccines: novel ...... y for overcoming the barriers.
@en
P2093
Jian-Qing Gao
Li-Hua Peng
Shinsaku Nakagawa
P304
P356
10.1016/J.VACCINE.2011.06.086
P407
P577
2011-07-06T00:00:00Z